Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 18
1970 47
1971 65
1972 58
1973 70
1974 67
1975 62
1976 51
1977 45
1978 33
1979 35
1980 42
1981 33
1982 39
1983 55
1984 77
1985 73
1986 74
1987 66
1988 86
1989 98
1990 156
1991 216
1992 295
1993 334
1994 345
1995 306
1996 334
1997 405
1998 386
1999 391
2000 368
2001 344
2002 369
2003 345
2004 397
2005 351
2006 410
2007 384
2008 317
2009 343
2010 375
2011 431
2012 404
2013 345
2014 379
2015 372
2016 302
2017 322
2018 313
2019 317
2020 330
2021 287
2022 188
Text availability
Article attribute
Article type
Publication date

Search Results

11,518 results
Results by year
Filters applied: . Clear all
Page 1
Is glyburide safe in pregnancy?
Kimber-Trojnar Ż, Marciniak B, Patro-Malysza J, Skorzynska-Dziduszko K, Poniedzialek-Czajkowska E, Mierzynski R, Galczynski K, Trojnar M, Leszczynska-Gorzelak B, Oleszczuk J. Kimber-Trojnar Ż, et al. Curr Pharm Biotechnol. 2014;15(1):100-12. doi: 10.2174/1389201015666140330200254. Curr Pharm Biotechnol. 2014. PMID: 24720590 Review.
It is therefore highly desirable to find an effective alternative to insulin. Glyburide (also known as glibenclamide) is currently classified as Category C by the U.S. ...Since the contradictory data primarily concern the transfer of glyburide across t …
It is therefore highly desirable to find an effective alternative to insulin. Glyburide (also known as glibenclamide) is curre …
Glibenclamide--what dose?
Rambiritch V, Pillai G, Maharaj B, Robertson LI. Rambiritch V, et al. S Afr Med J. 2007 Jul;97(7):475. S Afr Med J. 2007. PMID: 17805443 No abstract available.
Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine.
Mehboob S, Mehboob M, Mehjabeen -, Tariq Rafi SM, Khan T, Anser H, Perveen S, Jahan N, Wazir A, Owais F. Mehboob S, et al. Pak J Pharm Sci. 2021 Jul;34(4(Supplementary)):1639-1644. Pak J Pharm Sci. 2021. PMID: 34799342
Non insulin dependent diabetes mellitus (NIDDM) drugs such as glibenclamide and metformin is employed to heterogeneous disorder characterized by alteration in production of glucose due to impairment of both insulin secretion and insulin action. ...All drugs followed Beer L …
Non insulin dependent diabetes mellitus (NIDDM) drugs such as glibenclamide and metformin is employed to heterogeneous disorder chara …
[Somogyi's effect].
Mehnert H. Mehnert H. Dtsch Med Wochenschr. 1979 Mar 9;104(10):344. Dtsch Med Wochenschr. 1979. PMID: 107012 German. No abstract available.
[Glibenclamide as a promising agent for prevention and treatment of cerebral edema].
Tsarenko SV, Dzyadz'ko AM, Rybalko SS. Tsarenko SV, et al. Zh Vopr Neirokhir Im N N Burdenko. 2017;81(3):88-93. doi: 10.17116/neiro201781388-93. Zh Vopr Neirokhir Im N N Burdenko. 2017. PMID: 28665392 Free article. Review. Russian.
The article presents a review of the literature on the use of a fundamentally new technique for prevention and treatment of cerebral edema. A drug glibenclamide, which is used to treat type 2 diabetes mellitus, is able to reduce cerebral edema and neuronal damage as eviden …
The article presents a review of the literature on the use of a fundamentally new technique for prevention and treatment of cerebral edema. …
Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus.
Lamos EM, Stein SA, Davis SN. Lamos EM, et al. Expert Opin Pharmacother. 2012 Dec;13(17):2545-54. doi: 10.1517/14656566.2012.738196. Epub 2012 Nov 2. Expert Opin Pharmacother. 2012. PMID: 23116560 Review.
INTRODUCTION: Combination of glibenclamide (glyburide in the U.S.) and metformin hydrochloride simultaneously addresses two different but complimentary mechanisms to improve glycemic control in type 2 diabetes. AREAS COVERED: The pharmacokinetics, efficacy, a …
INTRODUCTION: Combination of glibenclamide (glyburide in the U.S.) and metformin hydrochloride simultaneously addresses …
Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment.
Hashem FM, Abd Allah FI, Abdel-Rashid RS, Hassan AAA. Hashem FM, et al. Drug Dev Ind Pharm. 2020 May;46(5):762-774. doi: 10.1080/03639045.2020.1753062. Epub 2020 Apr 20. Drug Dev Ind Pharm. 2020. PMID: 32250179
Objective: The development of nanosuspension for targeted delivery of glibenclamide as hypoglycemic agent to the lung in an inhaler dosage form.Method: Glibenclamide nanosuspension formulations were prepared using Box-Behnken design to investigate the effect of inde …
Objective: The development of nanosuspension for targeted delivery of glibenclamide as hypoglycemic agent to the lung in an inhaler d …
Glibenclamide-induced cholestasis.
Del-Val A, Garrigues V, Ponce J, Benages R. Del-Val A, et al. J Hepatol. 1991 Nov;13(3):375. doi: 10.1016/0168-8278(91)90085-p. J Hepatol. 1991. PMID: 1808229 No abstract available.
Mechanism of Action of Novel Glibenclamide Derivatives on Potassium and Calcium Channels for Insulin Secretion.
Frederico MJS, Castro AJG, Menegaz D, Murat CB, Mendes CP, Mascarello A, Nunes RJ, Silva FRMB. Frederico MJS, et al. Curr Drug Targets. 2017;18(6):641-650. doi: 10.2174/1389450117666160615084752. Curr Drug Targets. 2017. PMID: 27316908 Review.
Glibenclamide is widely used and remains a cornerstone and an effective antihyperglycemic drug. ...Furthermore, the role of glibenclamide-based novel structures that promise less excitability of beta-cell in a long-term treatment with effectiveness and safety for di
Glibenclamide is widely used and remains a cornerstone and an effective antihyperglycemic drug. ...Furthermore, the role of gliben
11,518 results
You have reached the last available page of results. Please see the User Guide for more information.